ArticleCancer immunology research2015

STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients.

Raghvendra M Srivastava et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.